During the past decade, Univ of Virginia Ophthalmology conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 5 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 5 clinical trials were completed. i.e. 500% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Univ of Virginia Ophthalmology" are "Diabetic Macular Edema" (3 trials), "Geographic Atrophy" (2 trials) and "Choroidal Neovascularization" (1 trials). Many other conditions were trialed in "Univ of Virginia Ophthalmology" in a lesser frequency.

Most popular intervention types in "Univ of Virginia Ophthalmology" are "Drug" (6 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Faricimab" (4 trials), "Sham Procedure" (3 trials), "Lampalizumab" (2 trials), "Ranibizumab" (2 trials) and "Aflibercept" (1 trials). Other intervention names were less common.

The vast majority of trials in "Univ of Virginia Ophthalmology" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Univ of Virginia Ophthalmology". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Univ of Virginia Ophthalmology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Univ of Virginia Ophthalmology, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".